| Literature DB >> 29881443 |
Wenxian Liang1,2, Xiaoxing Zou1,2, Rebeca Carballar-Lejarazú3, Lingjiao Wu1,2, Weihong Sun1,2, Xueyuan Yuan1,2, Songqing Wu1,2, Pengfei Li1,2, Hui Ding1,2, Lin Ni2,4, Wei Huang2,5, Shuangquan Zou1,2.
Abstract
BACKGROUND: Quantitative real-time reverse transcription-polymerase chain reaction has been widely used in gene expression analysis, however, to have reliable and accurate results, reference genes are necessary to normalize gene expression under different experimental conditions. Several reliable reference genes have been reported in plants of Traditional Chinese Medicine, but none have been identified for Euscaphis konishii Hayata.Entities:
Keywords: EkCAD1 gene; Euscaphis konishii Hayata; Gene expression; Normalization; Reference gene; Transcriptome; qRT-PCR
Year: 2018 PMID: 29881443 PMCID: PMC5985561 DOI: 10.1186/s13007-018-0311-x
Source DB: PubMed Journal: Plant Methods ISSN: 1746-4811 Impact factor: 4.993
Primers used for qRT-PCR normalization
| Gene abbreviation | Gene name | Primer sequence (5′–3′) | Amplicon length (bp) | Primers Tm (°C) | E (%) | R2 |
|---|---|---|---|---|---|---|
|
| For: TCTGCAGGTCCTTCAATTCC | 100 | 54.8/54.8 | 97.89 | 0.9998 | |
| Rev: CGCAAACCCTAGAGAGAGTAAG | ||||||
| For: CCAGTAACTCGCACCCTATTT | 96 | 54.44/54.56 | 99.59 | 0.9994 | ||
| Rev: TCACTGTCACTTTCCGATTCC | ||||||
|
| For: CCTTCATTACCCATCTCCCATC | 100 | 55.03/53.41 | 99.35 | 0.9878 | |
| Rev: CTAATGAATCCTCGTATGACTGGAT | ||||||
|
| For: GAGAGCGACAAGGGAATGAG | 108 | 55.7/54.8 | 100.09 | 0.9997 | |
| Rev: TATTACTGATGGTGCGCTGG | ||||||
|
| For: CATTGTGAGCAACTGGGATG | 125 | 54.01/54.21 | 103.21 | 0.9998 | |
| Rev: GATTAGCCTTCGGGTTGAGA | ||||||
|
| For: TGGCTTTCCGTGTTCCTACT | 113 | 56.14/57.12 | 101.1 | 0.9795 | |
| Rev: TCCCTCTGACTCCTCCTTGA | ||||||
| For: TCCGACATAGCTCCGATTCA | 101 | 55.42/55.4 | 98.46 | 0.9991 | ||
| Rev: GAAGAGACGGAGAGGAGAGATT | ||||||
|
| For: CCGAAGAGAATGTCCAGAAGAG | 98 | 54.97/54.48 | 99.89 | 0.9998 | |
| Rev: GTCCTTTGAGCTCGCATAGAT | ||||||
|
| For: AAAGATGAGCACCAAGGAGGT | 108 | 56.18/55.60 | 98.69 | 0.9879 | |
| Rev: TCACACACGCTGGATTTCAC | ||||||
|
| For: GGGAATCGGAGGTAAAGATCAA | 102 | 54/54 | 99.00 | 0.9822 | |
| Rev: TGGATCTGAAGAAATGGGAGAC | ||||||
|
| For: TTGGCCTCATCTATTGCTACTG | 98 | 54.3/55.4 | 101.00 | 0.9931 | |
| Rev: GTTCTCCTGTGCCCTCTAATG | ||||||
|
| For: GCCCTCATCCCAAACATACT | 113 | 54.6/54 | 98.99 | 0.9999 | |
| Rev: GAGATTGTTTGCAGCGAATAGG | ||||||
|
| For: GTGGGCTTTCCGTCAGTGTA | 123 | 59.97/59.97 | 99.23 | 0.9969 | |
| Rev: GGTCGGAGTTGGAGCTATCG |
Fig. 1Cq values of the twelve candidate reference genes. The lines across the box indicate median values, boxes depict 25/75 percentiles. Whisker caps indicate the minimum and maximum values
Gene expression stability across sample sets calculated by geNorm
| Gene name | Different tissues | Seed development stages | Capsule development stages | Total |
|---|---|---|---|---|
|
| 0.412 (5) | 0.369 (3) | 1.023 (12) | 0.491 (7) |
| 0.568 (8) | 1.201 (10) | 0.911 (11) | 0.428 (6) | |
|
| 0.390 (4) | 1.065 (9) | 0.398 (3) | 0.251 (3) |
|
| 0.599 (9) | 0.890 (8) | 0.753 (8) | 0.655 (8) |
|
| 0.498 (7) | 0.729 (7) | 0.646 (7) | 1.698 (12) |
|
| 0.315 (2) | 0.283 (2) | 0.254 (1) | 0.858 (10) |
| 0.752 (11) | 0.231 (1) | 0.568 (5) | 0.159 (2) | |
|
| 0.629 (10) | 0.649 (6) | 0.792 (9) | 0.134 (1) |
|
| 1.198 (12) | 1.216 (11) | 0.599 (6) | 1.421 (11) |
|
| 0.469 (6) | 0.534 (5) | 0.412 (4) | 0.699 (9) |
|
| 0.348 (3) | 1.368 (12) | 0.855 (10) | 0.284 (4) |
|
| 0.269 (1) | 0.412 (4) | 0.289 (2) | 0.344 (5) |
Fig. 2Average expression stability (M-value) of 12 candidate genes calculated by geNorm and ranking of the candidate reference genes in different experimental group. Tissues: five tissues sample sets; DSS: seed development stages; DSC: capsule development stages. Total: all samples
Fig. 3Optimal number of reference genes in different experimental groups using the geNorm. Pairwise variation (Vn/Vn + 1) analysis between normalization factors (NFn and NFn + 1) to calculate the number of reference genes in each experimental group. Tissues: five tissues sample sets; DSS: seed development stages; DSC: capsule development stages. Total: all samples
Gene expression stability across sample sets calculated by NormFinder
| Gene name | Different tissues | Seed development stages | Capsule development stages | Total |
|---|---|---|---|---|
|
| 0.268 (6) | 0.239 (3) | 0.391 (11) | 0.274 (8) |
| 0.331 (7) | 0.392 (10) | 0.414 (12) | 0.201 (6) | |
|
| 0.256 (3) | 0.601 (12) | 0.178 (3) | 0.103 (4) |
|
| 0.367 (9) | 0.521 (11) | 0.369 (8) | 0.348 (9) |
|
| 0.546 (11) | 0.379 (9) | 0.365 (7) | 1.495 (12) |
|
| 0.240 (2) | 0.171 (2) | 0.102 (1) | 0.493 (10) |
| 0.338 (8) | 0.153 (1) | 0.295 (6) | 0.090 (2) | |
|
| 0.458 (10) | 0.358 (8) | 0.384 (10) | 0.035 (1) |
|
| 0.806 (12) | 0.349 (7) | 0.286 (5) | 1.131 (11) |
|
| 0.261 (5) | 0.273 (4) | 0.251 (4) | 0.259 (7) |
|
| 0.256 (3) | 0.302 (6) | 0.371 (9) | 0.102 (3) |
|
| 0.165 (1) | 0.285 (5) | 0.116 (2) | 0.159 (5) |
Fig. 4Relative expression of EkCAD1 in different tissues. EkGSTU1, EkGAPDH and EkGSTU1 + EkGAPDH were used as one or two most stable reference genes, EkTUB was used as the least stable reference gene. Data are represented as mean ± SD, different words indicate significant difference of the expression of the target gene based on three biological replications (P < 0.05, t test; n = 3)